National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table, 21187-21188 [2014-08395]

Download as PDF Federal Register / Vol. 79, No. 72 / Tuesday, April 15, 2014 / Proposed Rules this action merely proposes to approve state law as meeting federal requirements and does not impose additional requirements beyond those imposed by state law. For that reason, this action: • Is not a ‘‘significant regulatory action’’ subject to review by the Office of Management and Budget under Executive Order 12866 (58 FR 51735, October 4, 1993); • does not impose an information collection burden under the provisions of the Paperwork Reduction Act (44 U.S.C. 3501 et seq.); • is certified as not having a significant economic impact on a substantial number of small entities under the Regulatory Flexibility Act (5 U.S.C. 601 et seq.); • does not contain any unfunded mandate or significantly or uniquely affect small governments, as described in the Unfunded Mandates Reform Act of 1995 (Pub. L. 104–4); • does not have federalism implications as specified in Executive Order 13132 (64 FR 43255, August 10, 1999); • is not an economically significant regulatory action based on health or safety risks subject to Executive Order 13045 (62 FR 19885, April 23, 1997); • is not a significant regulatory action subject to Executive Order 13211 (66 FR 28355, May 22, 2001); • is not subject to requirements of section 12(d) of the National Technology Transfer and Advancement Act of 1995 (15 U.S.C. 272 note) because application of those requirements would be inconsistent with the CAA; and • does not provide EPA with the discretionary authority to address, as appropriate, disproportionate human health or environmental effects, using practicable and legally permissible methods, under Executive Order 12898 (59 FR 7629, February 16, 1994). In addition, this proposed rule does not have tribal implications as specified by Executive Order 13175 (65 FR 67249, November 9, 2000), because the SIP is not approved to apply in Indian country located in the state, and EPA notes that it will not impose substantial direct costs on tribal governments or preempt tribal law. ehiers on DSK2VPTVN1PROD with PROPOSALS-1 List of Subjects in 40 CFR Part 52 Environmental protection, Air pollution control, Incorporation by reference, Intergovernmental relations, Nitrogen dioxides, Ozone, Particulate matter, Reporting and recordkeeping requirements, Volatile organic compounds. Authority: 42 U.S.C. 7401 et seq. VerDate Mar<15>2010 14:49 Apr 14, 2014 Jkt 232001 Dated: March 27, 2014. Ron Curry, Regional Administrator, Region 6. [FR Doc. 2014–08342 Filed 4–14–14; 8:45 am] BILLING CODE 6560–50–P ENVIRONMENTAL PROTECTION AGENCY 40 CFR Part 62 [EPA–R07–OAR–2013–0692; FRL 9909–44– Region 7] Approval and Promulgation of State Plans for Designated Facilities and Pollutants; Air Emissions From Existing Municipal Solid Waste Landfills; State of Missouri Environmental Protection Agency (EPA). ACTION: Proposed rule. AGENCY: The Environmental Protection Agency (EPA) is proposing to approve the revision to the state section 111 plan submitted by the State of Missouri for controlling emissions from existing municipal solid waste (MSW) landfills. The revised State Plan incorporates revisions to the Emissions Guidelines (EG) for MSW landfills promulgated by EPA in 2000 and 2006. The plan also corrects typographical and administrative changes in the Missouri rules. The plan was submitted to fulfill the requirements of section 111 of the Clean Air Act (CAA). DATES: Comments on this proposed action must be received in writing by May 15, 2014. ADDRESSES: Submit your comments, identified by Docket ID No. EPA–R07– OAR–2013–0692, by mail to Craig Bernstein, Environmental Protection Agency, Air Planning and Development Branch, 11201 Renner Boulevard, Lenexa, Kansas 66219. Comments may also be submitted electronically or through hand delivery/courier by following the detailed instructions in the ADDRESSES section of the direct final rule located in the rules section of this Federal Register. FOR FURTHER INFORMATION CONTACT: Craig Bernstein, Environmental Protection Agency, Air Planning and Development Branch, 11201 Renner Boulevard, Lenexa, Kansas 66219; at 913–551–7688; or by email at Bernstein.craig@epa.gov. SUPPLEMENTARY INFORMATION: In the final rules section of today’s Federal Register, EPA is approving the state’s 111(d) plan revision as a direct final rule without prior proposal because the Agency views this as a noncontroversial SUMMARY: PO 00000 Frm 00035 Fmt 4702 Sfmt 4702 21187 action and anticipates no relevant adverse comments because the revisions are administrative and consistent with Federal regulations. A detailed rationale for the approval is set forth in the direct final rule. If no relevant adverse comments are received in response to this action, no further activity is contemplated in relation to this action. If EPA receives relevant adverse comments, the direct final rule will be withdrawn and all public comments received will be addressed in a subsequent final rule based on this proposed action. EPA will not institute a second comment period on this action. Any parties interested in commenting on this action should do so at this time. Please note that if EPA receives adverse comment on part of this rule and if that part can be severed from the remainder of the rule, EPA may adopt as final those parts of the rule that are not the subject of an adverse comment. For additional information, see the direct final rule which is located in the rules section of this Federal Register. Dated: April 3, 2014. Karl Brooks, Regional Administrator, Region 7. [FR Doc. 2014–08337 Filed 4–14–14; 8:45 am] BILLING CODE 6560–50–P DEPARTMENT OF HEALTH AND HUMAN SERVICES 42 CFR Part 100 RIN 0906–AB00 National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table Office of the Secretary, HHS. Notice of public hearing. AGENCY: ACTION: This document announces a public hearing to receive information and views on the Notice of Proposed Rulemaking (NPRM) entitled ‘‘National Vaccine Injury Compensation Program: Revisions to the Vaccine Injury Table.’’ DATES: The public hearing will be held on April 28, 2014, from 10:00 a.m.– 11:30 a.m. (EDT). ADDRESSES: The public hearing will be held in Conference Room 10–65 in the Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. FOR FURTHER INFORMATION CONTACT: Dr. Avril Melissa Houston, Acting Director, Division of Vaccine Injury Compensation, at 855–266–2427 or by email at ahouston@hrsa.gov. SUPPLEMENTARY INFORMATION: The National Childhood Vaccine Injury Act SUMMARY: E:\FR\FM\15APP1.SGM 15APP1 ehiers on DSK2VPTVN1PROD with PROPOSALS-1 21188 Federal Register / Vol. 79, No. 72 / Tuesday, April 15, 2014 / Proposed Rules of 1986, Title III of Public Law 99–660, as amended (42 U.S.C. 300aa–10 et seq.), established the National Vaccine Injury Compensation Program (VICP) for persons found to be injured by vaccines. The Secretary has taken the necessary initial steps to propose to amend the Vaccine Injury Table to add intussusception as an injury associated with rotavirus vaccines. The NPRM was published in the Federal Register, July 24, 2013: 78 FR 44512. The public comment period closed January 21, 2014. A public hearing will be held after the 180-day public comment period. This hearing is to provide an open forum for the presentation of information and views concerning all aspects of the NPRM by interested persons. In preparing a final regulation, the Secretary will consider the administrative record of this hearing along with all other written comments received during the comment period specified in the NPRM. Individuals or representatives of interested organizations are invited to participate in the public hearing in accord with the schedule and procedures set forth below. The hearing will be held on April 28, 2014, beginning at 10:00 a.m. (EDT) in Conference Room 10–65 in the Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Upon entering the Parklawn Building, persons who wish to attend the hearing will be required to call Ms. Annie Herzog at (301) 443–6634 to be escorted to Conference Room 10–65. The public can also join the meeting via audio conference call: Audio Conference Call: Dial 800–369– 3104 and provide the following information: Leaders Name: Dr. Melissa Houston Password: HRSA The presiding officer representing the Secretary, HHS, will be Dr. Avril Melissa Houston, Acting Director, Division of Vaccine Injury Compensation, Healthcare Systems Bureau (HSB), Health Resources and Services Administration. Persons who wish to participate are requested to file a notice of participation with the Department of Health and Human Services (HHS) on or before April 21, 2014. The notice should be mailed to the Division of Vaccine Injury Compensation, HSB, Room 11C–26, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857 or emailed to aherzog@hrsa.gov. To ensure timely handling, any outer envelope or the subject line of an email should be clearly marked ‘‘VICP NPRM Hearing.’’ The notice of participation should VerDate Mar<15>2010 14:49 Apr 14, 2014 Jkt 232001 contain the interested person’s name, address, email address, telephone number, any business or organizational affiliation of the person desiring to make a presentation, a brief summary of the presentation, and the approximate time requested for the presentation. Groups that have similar interests should consolidate their comments as part of one presentation. Time available for the hearing will be allocated among the persons who properly file notices of participation. If time permits, interested parties attending the hearing who did not submit notice of participation in advance will be allowed to make an oral presentation at the conclusion of the hearing. Persons who find that there is insufficient time to submit the required information in writing may give oral notice of participation by calling Annie Herzog, Division of Vaccine Injury Compensation, at (301) 443–6634, no later than April 21, 2014. After reviewing the notices of participation and accompanying information, HHS will schedule each appearance and notify each participant by mail, email, or telephone of the time allotted to the person(s) and the approximate time the person’s oral presentation is scheduled to begin. Written comments and transcripts of the hearing will be made available for public inspection as soon as they have been prepared, on weekdays (federal holidays excepted) between the hours of 8:30 a.m. and 5 p.m. (EDT) at the Division of Vaccine Injury Compensation, Room 11C–26, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857. Dated: April 9, 2014. Kathleen Sebelius, Secretary. [FR Doc. 2014–08395 Filed 4–14–14; 8:45 am] BILLING CODE 4165–15–P LEGAL SERVICES CORPORATION 45 CFR Part 1614 Private Attorney Involvement Legal Services Corporation. Notice of proposed rulemaking. AGENCY: ACTION: This proposed rule updates the Legal Services Corporation (LSC or Corporation) regulation on private attorney involvement (PAI) in the delivery of legal services to eligible clients. SUMMARY: Comments must be submitted by June 16, 2014. DATES: PO 00000 Frm 00036 Fmt 4702 Sfmt 4702 Written comments must be submitted to Stefanie K. Davis, Assistant General Counsel, Legal Services Corporation, 3333 K Street NW., Washington, DC 20007; (202) 337–6519 (fax) or pairulemaking@lsc.gov. Electronic submissions are preferred via email with attachments in Acrobat PDF format. Written comments sent to any other address or received after the end of the comment period may not be considered by LSC. FOR FURTHER INFORMATION CONTACT: Stefanie K. Davis, Assistant General Counsel, Legal Services Corporation, 3333 K Street NW., Washington, DC 20007, (202) 295–1563 (phone), (202) 337–6519 (fax), pairulemaking@lsc.gov. SUPPLEMENTARY INFORMATION: ADDRESSES: I. Regulatory History In 1981, LSC issued the first instruction (‘‘Instruction’’) implementing the Corporation’s policy that LSC funding recipients dedicate a percentage of their basic field grants to involving private attorneys in the delivery of legal services to eligible clients. 46 FR 61017, 61018, Dec. 14, 1981. The goal of the policy was to ensure that recipients would provide private attorneys with opportunities to give legal assistance to eligible clients ‘‘in the most effective and economical manner and consistent with the purposes and requirements of the Legal Services Corporation Act.’’ Id. at 61017. The Instruction gave recipients guidance on the types of opportunities that they could consider, such as engaging private attorneys in the direct representation of eligible clients or in providing community legal education. Id. at 61018. Recipients were directed to consider a number of factors in deciding which activities to pursue, including the legal needs of eligible clients, the recipient’s priorities, the most effective and economical means of providing legal assistance, linguistic and cultural barriers to effective advocacy, conflicts of interest between private attorneys and eligible clients, and the substantive expertise of the private attorneys participating in the recipients’ projects. Id. LSC reissued the Instruction without substantive change in 1983. 48 FR 53763, Nov. 29, 1983. LSC subsequently promulgated the PAI policy in a regulation published at 45 CFR part 1614. 49 FR 21328, May 21, 1984. The new regulation adopted the policy and procedures established by the Instruction in large part. The rule adopted an amount equivalent to 12.5% of a recipient’s basic field grant as the amount recipients were to spend on PAI activities. Id. The rule also adopted the E:\FR\FM\15APP1.SGM 15APP1

Agencies

[Federal Register Volume 79, Number 72 (Tuesday, April 15, 2014)]
[Proposed Rules]
[Pages 21187-21188]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-08395]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

42 CFR Part 100

RIN 0906-AB00


National Vaccine Injury Compensation Program: Revisions to the 
Vaccine Injury Table

AGENCY: Office of the Secretary, HHS.

ACTION: Notice of public hearing.

-----------------------------------------------------------------------

SUMMARY: This document announces a public hearing to receive 
information and views on the Notice of Proposed Rulemaking (NPRM) 
entitled ``National Vaccine Injury Compensation Program: Revisions to 
the Vaccine Injury Table.''

DATES: The public hearing will be held on April 28, 2014, from 10:00 
a.m.-11:30 a.m. (EDT).

ADDRESSES: The public hearing will be held in Conference Room 10-65 in 
the Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857.

FOR FURTHER INFORMATION CONTACT: Dr. Avril Melissa Houston, Acting 
Director, Division of Vaccine Injury Compensation, at 855-266-2427 or 
by email at ahouston@hrsa.gov.

SUPPLEMENTARY INFORMATION: The National Childhood Vaccine Injury Act

[[Page 21188]]

of 1986, Title III of Public Law 99-660, as amended (42 U.S.C. 300aa-10 
et seq.), established the National Vaccine Injury Compensation Program 
(VICP) for persons found to be injured by vaccines. The Secretary has 
taken the necessary initial steps to propose to amend the Vaccine 
Injury Table to add intussusception as an injury associated with 
rotavirus vaccines.
    The NPRM was published in the Federal Register, July 24, 2013: 78 
FR 44512. The public comment period closed January 21, 2014.
    A public hearing will be held after the 180-day public comment 
period. This hearing is to provide an open forum for the presentation 
of information and views concerning all aspects of the NPRM by 
interested persons.
    In preparing a final regulation, the Secretary will consider the 
administrative record of this hearing along with all other written 
comments received during the comment period specified in the NPRM. 
Individuals or representatives of interested organizations are invited 
to participate in the public hearing in accord with the schedule and 
procedures set forth below.
    The hearing will be held on April 28, 2014, beginning at 10:00 a.m. 
(EDT) in Conference Room 10-65 in the Parklawn Building, 5600 Fishers 
Lane, Rockville, Maryland 20857. Upon entering the Parklawn Building, 
persons who wish to attend the hearing will be required to call Ms. 
Annie Herzog at (301) 443-6634 to be escorted to Conference Room 10-65.
    The public can also join the meeting via audio conference call:
    Audio Conference Call: Dial 800-369-3104 and provide the following 
information:
    Leaders Name: Dr. Melissa Houston
    Password: HRSA
    The presiding officer representing the Secretary, HHS, will be Dr. 
Avril Melissa Houston, Acting Director, Division of Vaccine Injury 
Compensation, Healthcare Systems Bureau (HSB), Health Resources and 
Services Administration.
    Persons who wish to participate are requested to file a notice of 
participation with the Department of Health and Human Services (HHS) on 
or before April 21, 2014. The notice should be mailed to the Division 
of Vaccine Injury Compensation, HSB, Room 11C-26, Parklawn Building, 
5600 Fishers Lane, Rockville, Maryland 20857 or emailed to 
aherzog@hrsa.gov. To ensure timely handling, any outer envelope or the 
subject line of an email should be clearly marked ``VICP NPRM 
Hearing.'' The notice of participation should contain the interested 
person's name, address, email address, telephone number, any business 
or organizational affiliation of the person desiring to make a 
presentation, a brief summary of the presentation, and the approximate 
time requested for the presentation. Groups that have similar interests 
should consolidate their comments as part of one presentation. Time 
available for the hearing will be allocated among the persons who 
properly file notices of participation. If time permits, interested 
parties attending the hearing who did not submit notice of 
participation in advance will be allowed to make an oral presentation 
at the conclusion of the hearing.
    Persons who find that there is insufficient time to submit the 
required information in writing may give oral notice of participation 
by calling Annie Herzog, Division of Vaccine Injury Compensation, at 
(301) 443-6634, no later than April 21, 2014.
    After reviewing the notices of participation and accompanying 
information, HHS will schedule each appearance and notify each 
participant by mail, email, or telephone of the time allotted to the 
person(s) and the approximate time the person's oral presentation is 
scheduled to begin.
    Written comments and transcripts of the hearing will be made 
available for public inspection as soon as they have been prepared, on 
weekdays (federal holidays excepted) between the hours of 8:30 a.m. and 
5 p.m. (EDT) at the Division of Vaccine Injury Compensation, Room 11C-
26, Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 20857.

    Dated: April 9, 2014.
Kathleen Sebelius,
Secretary.
[FR Doc. 2014-08395 Filed 4-14-14; 8:45 am]
BILLING CODE 4165-15-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.